Articoli Scientifici su Riviste Impattate Ranolazine Attenuates Trastuzumab-Induced Heart Dysfunction by Modulating ROS Production di Redazione Dicembre 5, 2020 scritto da Redazione Dicembre 5, 2020 98 Articolo 0 commento Redazione messaggio precedente Cardioprotective Effects of Nanoemulsions Loaded with Anti-Inflammatory Nutraceuticals against Doxorubicin-Induced Cardiotoxicity prossimo post Management of QT prolongation induced by anti-cancer drugs: Target therapy and old agents. Different algorithms for different drugs Potrebbe piacerti anche “Women survive breast cancer but fall victim to heart failure: the shadows and lights of... Dicembre 5, 2020 “Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experience” Dicembre 5, 2020 “Intracardiac metastasis originated from chondrosarcoma” Dicembre 5, 2020 “Complete atrioventricular block in a patient with intracardiac metastases from malignant melanoma” Dicembre 5, 2020 “Comparison of preclinical cardiotoxic effects of different ErbB2 inhibitors” Dicembre 5, 2020 “Early identification of left ventricular dysfunction induced by trastuzumab” Dicembre 5, 2020 “Detection, monitoring, and management of trastuzumab-induced left ventricular dysfunction: an actual challenge” Dicembre 5, 2020 “Trastuzumab adjuvant chemotherapy and cardiotoxicity in real-world women with breast cancer” Dicembre 5, 2020 “Administration of angiotensin-coverting enzyme inhibitors and B-blockers during adjuvant trastuzumab chemotherapy for nonmetastatic breast cancer:... Dicembre 5, 2020 “Adjuvant trastuzumab cardiotoxicity in patients over 60 years of age with early breast cancer: a... Dicembre 5, 2020
